US Broker Ratings

STERIS plc (STE) Investor Outlook: Analyzing a 12.21% Potential Upside with Robust Revenue Growth

STERIS plc (NYSE: STE) stands out in the competitive healthcare sector as a prominent player in the medical devices industry. With a sprawling market capitalization of..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Exploring a 10.71% Upside Potential

Investors eyeing the healthcare sector might find GE HealthCare Technologies Inc. (NYSE: GEHC) an intriguing player, especially with its potential upside of 10.71%. As a prominent..

Revvity, Inc. (RVTY) Stock Analysis: Potential Upside and Strategic Positioning in Diagnostics & Research

Revvity, Inc. (NYSE: RVTY), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, offers compelling prospects for investors seeking opportunities in..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Evaluating a 14.55% Potential Upside in the Healthcare Sector

Lantheus Holdings, Inc. (NASDAQ: LNTH), a key player in the healthcare sector, stands out in the specialty and generic drug manufacturing industry. With a market cap..

Corcept Therapeutics (CORT): Investor Outlook and Potential 119% Upside

Corcept Therapeutics Incorporated (NASDAQ: CORT), a prominent player in the biotechnology sector, has captured the attention of investors with its promising pipeline and robust market position...

Qiagen N.V. (QGEN) Stock Analysis: Exploring a 13.71% Upside Potential in the Diagnostics & Research Sector

Qiagen N.V. (NASDAQ: QGEN), a prominent player in the diagnostics and research industry, continues to capture investor attention with its promising market positioning and potential upside...

Insmed Incorporated (INSM) Stock Analysis: Unveiling a 29% Potential Upside Amidst Robust Revenue Growth

In the dynamic realm of biotechnology, Insmed Incorporated (NASDAQ: INSM) stands out with its promising pipeline and robust revenue growth. With a market capitalization of $35.17..

Incyte Corporation (INCY) Stock Analysis: Examining the 5.7% Upside Potential Amid Robust Revenue Growth

Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology sector, is capturing investor attention with its impressive revenue growth and potential upside. With a market..

CVS Health Corporation (CVS) Stock Analysis: Strong Buy Ratings and 23.67% Potential Upside

CVS Health Corporation (NYSE: CVS), a prominent player in the healthcare sector, is currently stirring interest among investors with its robust analyst ratings and attractive growth..

Vaxcyte, Inc. (PCVX) Stock Analysis: Exploring a 74% Potential Upside in the Innovative Vaccine Sector

Vaxcyte, Inc. (PCVX) is generating significant attention in the biotechnology sector, largely due to its innovative approach to vaccine development and a notable potential upside of..

Encompass Health Corporation (EHC) Stock Report: Analyst Consensus Reveals 33.95% Upside Potential

Encompass Health Corporation (NYSE: EHC), a key player in the healthcare sector, has captured the attention of investors with its solid market presence and promising growth..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: Exploring Growth Potential with a 35.94% Upside

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leading name in the biotechnology industry, is capturing investor attention with its robust pipeline and significant growth potential. As a..

BioNTech SE (BNTX): Investor Outlook Reveals 26.79% Upside Potential Amid Robust Pipeline

BioNTech SE (NASDAQ: BNTX), a biotechnology powerhouse based in Mainz, Germany, has made impressive strides in the healthcare sector with its innovative approach to developing immunotherapies..

The Cigna Group (CI) Stock Analysis: Unlocking an 18.66% Potential Upside with Strong Buy Ratings

The Cigna Group (NYSE: CI), a titan in the healthcare plans industry, is drawing significant attention from investors seeking robust returns in a volatile market. With..

DexCom, Inc. (DXCM): Investor Outlook Highlights 16.94% Upside Potential and Strong Buy Ratings

DexCom, Inc. (NASDAQ: DXCM), a leader in the healthcare sector specializing in medical devices, primarily focuses on continuous glucose monitoring (CGM) systems that are vital for..

Axsome Therapeutics (AXSM): A Biotech Powerhouse with Promising Upside Potential and Strong Buy Consensus

Axsome Therapeutics, Inc. (AXSM), a prominent player in the biotechnology sector, has been making significant strides in the field of central nervous system (CNS) disorders. With..

Moderna, Inc. (MRNA) Stock Analysis: Navigating a -15.68% Potential Downside Amid Revenue Challenges

As a key player in the biotechnology sector, Moderna, Inc. (NASDAQ: MRNA) has been at the forefront of mRNA technology, revolutionizing how the world approaches vaccines..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Unpacking a Potential 37.5% Upside

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) is drawing significant attention from investors with its robust potential upside of 37.52%, as indicated by its average target price of..

Eli Lilly and Company (LLY) Stock Analysis: Exploring a 19.98% Potential Upside in the Healthcare Giant

Eli Lilly and Company (NYSE: LLY), a stalwart in the healthcare sector, continues to capture investor attention with its robust portfolio in pharmaceuticals. With a market..

Alkermes plc (ALKS) Stock Analysis: A Strong Buy with 37% Potential Upside

Individual investors eyeing opportunities in the biopharmaceutical sector may find Alkermes plc (NASDAQ: ALKS) a compelling consideration. As a leading player in the healthcare industry, Alkermes..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds